Posters

      Inflammatory And Epithelial Changes In Lungs From Apolipoprotein-E-Deficient Mice After Chronic Cigarette Mainstream Smoke Exposure

      Lebrun, S.; Stinn, W.; Weiler, H.; Friedrichs, B.; Büttner, A.; von Holt, K.; Wallerath, T.; Schleef, R.; H-Haussmann, H-J. Haussmann.
      Conference date
      Sep 20, 2006
      Conference name
      Eurotox 2006
      Link to more information
      Link to more information
      Topic
      Summary

      Inflammation plays a key role in the atherosclerotic process. As part of a study on the influence of cigarette mainstream smoke (ms) in combination with high-fat diet on the development of atherosclerosis, we investigated the inflammatory response and histopathological alterations in lungs from Apolipoprotein E-deficient (ApoE -/-) mice, a classic model for atherosclerosis. Male ApoE -/- mice were whole-body exposed for 12 months (6 h/d, 5 d/wk) to diluted MS at total particulate matter (TPM) concentrations of 100 and 200 μg/l or to filtered fresh air. Each exposure group was fed either a chow diet or a milk-fat-enriched diet. Bronchoalveolar lavage (BAL) was performed and inflammatory cells were quantified in BAL fluid (BALF); lungs were evaluated histopathologically. Mice exposed to 100 μg TPM/l MS showed no statistically significant inflammatory and epithelial changes in the lung. Mice exposed to 200 μg TPM/l MS showed statistically significant inflammatory changes, i.e., a constant elevation of neutrophils and a continuous increase in lymphocytes in BALF with both diets. In the high-fat diet groups, there was a tendency to a greater increase in neutrophils and lymphocytes. Pathomorphological findings observed in the lungs of mice exposed to 200 μg TPM/l MS included multifocal alveolar histiocytosis present as single macrophages and pigmented macrophage nests (PMN). Hypertrophy/hyperplasia of the alveolar epithelium was seen only in single cells directly associated with the PMN. The incidence of these pathomorphological findings increased from 20% after 3 months of exposure to 80% after 12 months of exposure in both diets. Interstitial lymphocytic infiltrates were present in 80% of these mice only after 12 months of exposure. The pathomorphological alterations were not influenced by high-fat diet. In summary, our data indicate that chronic exposure of ApoE -/- mice to 200 μg TPM/l MS results in non-neoplastic pathomorphological changes in the lung and an inflammatory response, which is a mixture of innate and adaptive immune responses, as indicated by an increase in BALF neutrophils and lymphocytes. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.